RARE downgraded to market perform from outperform by William Blair
William Blair has cut Ultragenyx Pharma’s rating on RARE to market perform from outperform, according to TradingView News via Benzinga ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.